levodopa has been researched along with Manganese Poisoning in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (38.46) | 18.7374 |
| 1990's | 5 (19.23) | 18.2507 |
| 2000's | 8 (30.77) | 29.6817 |
| 2010's | 3 (11.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bustamante, ML; Lees, A; Mena, F; Miranda, M | 1 |
| Anaya-Martínez, V; Avila-Costa, MR; Espinosa-Villanueva, J; Gutierrez-Valdez, AL; Montiel-Flores, E; Ordoñez-Librado, JL; Reynoso-Erazo, L; Sanchez-Betancourt, J | 1 |
| Butterworth, RF | 1 |
| Koller, WC; Lyons, KE; Truly, W | 1 |
| Chu, NS | 1 |
| Antenor, JA; Kotagal, V; McGee-Minnich, L; Moerlein, SM; Perlmutter, JS; Racette, BA; Videen, TO | 1 |
| Weiss, B | 1 |
| Cersosimo, MG; Koller, WC | 1 |
| Tang, LC | 1 |
| Barbeau, A | 1 |
| Schunk, W | 1 |
| Chandra, SV; Shukla, GS | 1 |
| Calne, DB; Doudet, D; Hewitt, KA; Nugent, R; Olanow, W; Pate, BD; Perl, DP; Shinotoh, H; Snow, BJ | 1 |
| Calne, DB; Chu, NS; Huang, CC; Lu, CS | 1 |
| Graham, DG; Linney, E; Montine, TJ; Underhill, TM | 1 |
| Beal, MF; Calne, DB; Good, PF; Hewitt, KA; Olanow, CW; Perl, DP; Shinotoh, H; Snow, BJ; Vingerhoets, F | 1 |
| De Natale, G; Delogu, MR; Desole, MS; Godani, C; Miele, E; Migheli, R; Sciola, L; Serra, PA; Zangani, D | 1 |
| Bleich, S; Degner, D; Poser, W; Riegel, A; Rüther, E; Sprung, R | 1 |
| Liu, MC; Ranasinghe, JG; Sakakibara, Y; Suiko, M | 1 |
| Discalzi, G; Herrero Hernandez, E; Meliga, F; Pira, E; Turbiglio, M; Valentini, C | 1 |
| Cotzias, GC; Mena, I; Mendez, JS; Papavasiliou, PS | 1 |
| Aranda, L; Court, J; Horiuchi, K; López, G; Mena, I | 1 |
| Barbeau, A; Cloutier, T; Inoué, N | 1 |
| Flauto, C; Groppetti, A; Parati, E; Parenti, M; Vescovi, A | 1 |
| Adamkov, J; Fundárek, J; Sútorová, D | 1 |
| Cotzias, GC | 1 |
3 review(s) available for levodopa and Manganese Poisoning
| Article | Year |
|---|---|
Parkinsonism in cirrhosis: pathogenesis and current therapeutic options.
Topics: Antiparkinson Agents; Brain Chemistry; Chelating Agents; Dopamine; Dopamine Agents; Humans; Hyperammonemia; Levodopa; Liver Cirrhosis; Liver Transplantation; Manganese Poisoning; Parkinson Disease | 2013 |
Economic implications of manganese neurotoxicity.
Topics: Adult; Age Factors; Aged; Animals; Female; Humans; Intelligence; Levodopa; Male; Manganese Poisoning; Middle Aged; Neural Pathways; Neurotoxicity Syndromes; Parkinson Disease; Risk Factors | 2006 |
The diagnosis of manganese-induced parkinsonism.
Topics: Adult; Diagnosis, Differential; Dopamine Agents; Humans; Levodopa; Male; Manganese Poisoning; Middle Aged; Parkinsonian Disorders | 2006 |
2 trial(s) available for levodopa and Manganese Poisoning
| Article | Year |
|---|---|
Effect of levodopa treatment for parkinsonism in welders: A double-blind study.
Topics: Aged; Antiparkinson Agents; Cross-Over Studies; Double-Blind Method; Humans; Levodopa; Male; Manganese Poisoning; Middle Aged; Parkinson Disease, Secondary; Welding | 2004 |
Levodopa failure in chronic manganism.
Topics: Adult; Chronic Disease; Double-Blind Method; Humans; Levodopa; Male; Manganese Poisoning; Middle Aged; Movement Disorders; Nervous System Diseases; Placebos | 1994 |
21 other study(ies) available for levodopa and Manganese Poisoning
| Article | Year |
|---|---|
Original footage of the Chilean miners with manganism published in Neurology in 1967.
Topics: Chile; History, 20th Century; Humans; Levodopa; Male; Manganese Poisoning; Miners; Neurology; Occupational Exposure | 2015 |
Manganese mixture inhalation is a reliable Parkinson disease model in rats.
Topics: Administration, Inhalation; Analysis of Variance; Animals; Antiparkinson Agents; Brain; Disease Models, Animal; Feeding Behavior; Levodopa; Locomotion; Male; Manganese Compounds; Manganese Poisoning; Mice; Motor Activity; Neurologic Examination; Parkinson Disease; Phosphopyruvate Hydratase; Psychomotor Performance; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase; Video Recording | 2012 |
Effect of levodopa treatment for parkinsonism in welders: a double-blind study.
Topics: Age of Onset; Brain; Clinical Trials as Topic; Diagnosis, Differential; Diagnostic Errors; Dopamine Agents; Double-Blind Method; Dystonia; Gait Disorders, Neurologic; Humans; Levodopa; Manganese; Manganese Poisoning; Occupational Exposure; Parkinson Disease, Secondary; Tremor; Welding | 2004 |
[18F]FDOPA PET and clinical features in parkinsonism due to manganism.
Topics: Adult; Antiparkinson Agents; Brain; Carbidopa; Drug Combinations; Female; Fluorodeoxyglucose F18; Gait; Humans; Levodopa; Magnetic Resonance Imaging; Manganese Poisoning; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
A personal and scientific biography of Dr. George C. Cotzias.
Topics: Brain Chemistry; Dihydroxyphenylalanine; Dopamine; History, 20th Century; Humans; Levodopa; Manganese Poisoning; Parkinson Disease; Trace Elements | 1984 |
Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias).
Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Brain Chemistry; Catecholamines; Disease Models, Animal; Humans; Levodopa; Manganese; Manganese Poisoning; Melanins; Melanocyte-Stimulating Hormones; Parkinson Disease; Substantia Nigra | 1984 |
[New aspects of chronic occupational manganese poisoning].
Topics: Amantadine; Diagnosis, Differential; Humans; Levodopa; Manganese Poisoning; Occupational Diseases; Parkinson Disease, Secondary | 1982 |
Striatal dopamine turnover and L-dopa treatment after short-term exposure of rats to manganese.
Topics: Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Levodopa; Manganese; Manganese Poisoning; Rats | 1981 |
MRI and PET studies of manganese-intoxicated monkeys.
Topics: Animals; Carbidopa; Corpus Striatum; Deoxyglucose; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Globus Pallidus; Glucose; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Male; Manganese Poisoning; Parkinson Disease, Secondary; Raclopride; Salicylamides; Substantia Nigra; Tomography, Emission-Computed | 1995 |
Fibroblasts that express aromatic amino acid decarboxylase have increased sensitivity to the synergistic cytotoxicity of L-dopa and manganese.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Cell Survival; CHO Cells; Chromatography, High Pressure Liquid; Cricetinae; Dopamine; Drug Synergism; Fibroblasts; Levodopa; Manganese Poisoning; Transfection | 1994 |
Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study.
Topics: Animals; Basal Ganglia; Brain; Carbidopa; Chlorides; Gliosis; Globus Pallidus; Levodopa; Macaca mulatta; Male; Manganese Compounds; Manganese Poisoning; Parkinson Disease, Secondary; Poisoning; Substantia Nigra | 1996 |
Enhancing effect of manganese on L-DOPA-induced apoptosis in PC12 cells: role of oxidative stress.
Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Ascorbic Acid; Cell Survival; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Drug Synergism; Flow Cytometry; Levodopa; Manganese Poisoning; Oxidative Stress; PC12 Cells; Rats | 1999 |
[Follow-up study after enteral manganese poisoning: clinical, laboratory and neuroradiological findings].
Topics: Aged; Aged, 80 and over; Brain; Humans; Levodopa; Magnetic Resonance Imaging; Male; Manganese Poisoning; Parkinson Disease, Secondary; Polyneuropathies; Potassium Permanganate; Psychiatric Status Rating Scales; Remission, Spontaneous | 2000 |
Manganese administration induces the increased production of dopamine sulfate and depletion of dopamine in Sprague-Dawley rats.
Topics: Administration, Oral; Animals; Brain; Chromatography, High Pressure Liquid; Dopamine; Heart; Kidney; Levodopa; Liver; Male; Manganese; Manganese Poisoning; Rats; Rats, Sprague-Dawley; Tyrosine | 2000 |
Occupational Mn parkinsonism: magnetic resonance imaging and clinical patterns following CaNa2-EDTA chelation.
Topics: Antiparkinson Agents; Benserazide; Brain; Chelating Agents; Edetic Acid; Globus Pallidus; Humans; Levodopa; Magnetic Resonance Imaging; Male; Manganese Poisoning; Metals, Heavy; Middle Aged; Occupational Diseases; Occupational Exposure; Parkinsonian Disorders | 2000 |
Diphenylhydantoin. Blocking of levodopa effects.
Topics: Adult; Aged; Dopamine; Female; Humans; Huntington Disease; Levodopa; Male; Manganese Poisoning; Middle Aged; Movement Disorders; Neurons; Parkinson Disease; Phenytoin; Receptors, Adrenergic | 1975 |
[Sleep stages and growth hormone in manganese poisoning. Effects of L dopa].
Topics: Adult; Aged; Growth Hormone; Humans; Levodopa; Manganese Poisoning; Middle Aged; Sleep, REM | 1976 |
Role of manganese in dystonia.
Topics: Animals; Brain; Brain Chemistry; Dogs; Dystonia Musculorum Deformans; Functional Laterality; Gait; Haplorhini; Humans; Levodopa; Manganese; Manganese Poisoning; Movement Disorders; Parkinson Disease; Rabbits; Rats; Synapses; Syndrome | 1976 |
Manganese neurotoxicity: effects of L-DOPA and pargyline treatments.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Basal Ganglia Diseases; Corpus Striatum; Dopamine; Drug Synergism; Hydroxyindoleacetic Acid; Levodopa; Male; Manganese Poisoning; Pargyline; Parkinson Disease; Rats; Serotonin | 1986 |
[Neurologic and electromyographic findings in chronic manganese encephalopathy].
Topics: Adult; Brain Diseases; Carbidopa; Chronic Disease; Drug Combinations; Electromyography; Humans; Levodopa; Male; Manganese Poisoning; Metallurgy; Middle Aged; Occupational Diseases | 1986 |
Levodopa, manganese, and degenerations of the brain.
Topics: Administration, Oral; Animals; Apomorphine; Blood Urea Nitrogen; Brain Diseases; Carbon Radioisotopes; Chemical Phenomena; Chemistry; Chronic Disease; Dietary Proteins; Dopamine; Drug Therapy, Combination; Growth Hormone; Humans; Injections; Levodopa; Manganese Poisoning; Movement Disorders; Neutron Activation Analysis; Parkinson Disease; Psychoses, Substance-Induced; Radioisotopes | 1974 |